New PARP Inhibitor Abiraterone Combo in Met Prostate Cancer: ASCO 2018 GU Highlights
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
Dr. Daniel Goldstein considers new data by Clarke & colleagues on a combination of the ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
